Investment company venBio Partners L.P. buys Menlo Therapeutics Inc during the 3-months ended 2018-03-31, according to the most recent filings of the investment company, venBio Partners L.P.. As of 2018-03-31, venBio Partners L.P. owns 3 stocks with a total value of $83 million. These are the details of the buys and sells.
New Purchases: MNLO,
For the details of venBio Partners L.P.’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=venBio+Partners+L.P.
These are the top 5 holdings of venBio Partners L.P.Menlo Therapeutics Inc (MNLO) – 1,461,552 shares, 66.09% of the total portfolio. New PositionVerona Pharma PLC (VRNA) – 875,000 shares, 21.06% of the total portfolio. Nabriva Therapeutics PLC (NBRV) – 2,122,962 shares, 12.85% of the total portfolio. New Purchase: Menlo Therapeutics Inc (MNLO)
venBio Partners L.P. initiated holding in Menlo Therapeutics Inc. The purchase prices were between $28.51 and $37.82, with an estimated average price of $33.81. The stock is now traded at around $7.91. The impact to a portfolio due to this purchase was 66.09%. The holding were 1,461,552 shares as of 2018-03-31.
Here is the complete portfolio of venBio Partners L.P.. Also check out:
1. venBio Partners L.P.’s Undervalued Stocks
2. venBio Partners L.P.’s Top Growth Companies, and
3. venBio Partners L.P.’s High Yield stocks
4. Stocks that venBio Partners L.P. keeps buying
